Special Issue "Current Issues and Future Developments in the Surgical Treatment of Upper Gastrointestinal Tract Cancer"
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "General Surgery".
Deadline for manuscript submissions: 25 January 2024 | Viewed by 1814
Special Issue Editors
Interests: gastro-esophageal cancer; obesity surgery; laparoscopic gastrointestinal surgery; complex ab-dominal hernia surgery
Interests: surgical oncology; upper GI cancer; esophageal cancer; gastric cancer; clinical trials; minimally invasive surgery; robotic surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Upper gastrointestinal tract surgery is constantly evolving with robotic surgery, and is gaining in importance. At the same time, laparoscopic techniques have been implemented as the standard approach for both early and advanced tumor stages. While anastomotic techniques and the extent of lymph node dissection are currently debated, the management and prevention of complications and failure to rescue play an important role in clinical routine. Future developments will include the progress of robotic surgery, standardized surgical training and the implementation of novel technologies such as machine learning and artificial intelligence.
For this Special Issue, we invite manuscripts addressing:
- Robotic surgery;
- Surgical training;
- Minimally invasive techniques;
- Complication management;
- Machine learning and artificial intelligence;
- Future and novels strategies;
- Quality improvement.
In regard to these important aspects and perspectives, Journal of Clinical Medicine provides a Special Issue on current clinical issues and future aspects of the diagnosis and treatment of upper gastrointestinal tract cancer. We welcome high-quality research including original studies, meta-analyses and reviews.
Dr. Christian Denecke
Prof. Dr. Matthias Biebl
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- complication management
- surgical techniques
- training
- future technologies
- robotic surgery
- artificial intelligence
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
- The Challenge of Achieving Textbook Outcome after laparoscopic total Gastrectomy for Gastric Cancer
- The Learning Curve for Ivor Lewis Minimally Invasive Esophagectomy – a single high volume centre experience
- The Association between Tumor Response and Perioperative Outcome after Neoadjuvant Chemotherapy in Patients with Gastroesophageal Adenocarcinoma.